Assess the Clinical Effectiveness in AI Prioritising CT Heads
NCT ID: NCT06027411
Last Updated: 2024-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
16800 participants
OBSERVATIONAL
2024-03-27
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Radiologists, those reporting scans, often have significant backlogs and are unable to prioritise abnormal images of patients with time critical abnormalities. Similarly, identification of normal scans would support patient turnover in ED with significant waits and pressure on resources.
To address this problem, Qure.AI has worked to develop the market approved qER algorithm, which is a software program that can analyse CT head to identify presence of abnormalities supporting workflow prioritisation.
This study will trial the software in 4 NHS hospitals across the UK to evaluate the ability of the software to reduce the turnaround time of reporting scans with abnormalities that need to be prioritised.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
NCT06018545
Retrospective Study on the Direction of Artificial Intelligence in Identifying Cranial Trauma CT Imaging
NCT06230419
Acute Concussion Management in Emergency Medicine with 7T MRI: a Feasibility Study
NCT06830616
Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients
NCT07100132
Simulation Training in Emergency Department Imaging 2
NCT05427838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Emergency Departments (ED) across the UK are overburdened with increasing patient demand, radiology staff shortages and rising patient wait times. Head injuries are a frequent cause of emergency attendance in the UK with computed tomography(CT) scans usually the first imaging tests to diagnose head injuries and strokes.
A report issued by National Institute of Health and Care Excellence (NICE), confirms that each year 1.4 million people attend emergency departments in England and Wales with head injury. Among the 200,000 patients admitted annually, one-fifth of them suffer from a Traumatic Brain Injury with skull fracture or evidence of brain damage. Head injury is the most common cause of death and disability in people up to the age of 40. Early detection and prompt treatment is vital to save lives and minimise risk of disability, according to the NICE guidelines of Head injury: assessment and early management. Head CT scans are the gold standard for diagnosing these and it is critical that these are performed and reported by Radiologists in line with NICE guidelines.
The potential applications of AI in radiology go well beyond image analysis for diagnostic and prognostic opportunities. It is becoming increasingly clear that AI algorithms have the potential to improve productivity, operational efficiency, and accuracy in diagnostic radiology. AI tools are being developed to aide diagnosis and enhance processes at multiple point in the radiology workflow including:
(a) protocolling the prioritised scan,(b) clinical decision support systems for detection of critical findings, (c) worklist priority adjustment via AI results, and (d) reducing turnaround time through worklist prioritisation and semiautomated structures reporting. The adoption of AI tools is dependent on the demonstration of a tangible effect on patient care and improvement in radiologist workflow.
Thus, in this study, we aim to assess whether real-world implementation of an AI tool which augments (b), (c) and (d) of the imaging life cycle would affect turnaround times.
qER medical device:
qER, a CE Class II approved medical software device, detects, and localizes the presence of six target abnormalities - intracranial haemorrhage, cranial fracture, midline shift, mass effect, atrophy and hypodensities suggestive of infarcts in non-contrast Head-CT scans. A priority status is assigned if any one of the target abnormalities (intracranial haemorrhage, cranial fracture, midline shift or mass effect) is detected by the software, and the user will be able to view a single summary slice listing all the target abnormalities found by qER on the CT scan followed by all slices in scan with the overlay of above abnormalities localization. Alternately, if none of the target abnormalities are detected, the output will indicate that the software has analysed the image and identified no critical findings. qER reports are intended to support certified radiologists and/or licensed medical practitioners for clinical decision making. It is a support tool and, when used with original scans, can assist the clinician to improve efficiency, accuracy, and turnaround time in reading head CTs. It is not to be used to provide medical advice, determine treatment plan, or recommend a course of action to the patient.
Study design:
A multi-centre stepped wedged cluster randomised study will be conducted in 4 NHS hospitals over a 13-month period. Hospitals will be identified and initiated into the qER solution with a 30-day implementation period. The order in which sites will receive the qER intervention will be determined by computer-based randomisation. The stepped wedge design allows delivery of the intervention at an organisational level with evaluation of outcome measures at a patient level. Structuring the implementation through a staged activation in a random order provides important methodological advantages for both qualitative and quantitative elements of the study. The design allows control of adoption bias and adjust for time-based changes in the background patient characteristics at a patient level.
All patients under this pathway would receive an AI reading, and no additional or different tests will be performed as a result of the AI findings. The turnaround time will be the interval between the time the scan was taken to the time when the final scan report becomes available and will be measured in minutes. When qER assistance is used for reporting Head-CT scans and if there is a difference between the output of the qER and the radiologist, the latter will be considered as final for further patient management.
Primary objective:
The primary objective is to assess if qER based reporting and triage significantly reduce turnaround time (TAT) of critical NCCT head reporting for patients attending the emergency department.
Secondary objective(s):
* To assess utility of qER to support emergency department pathways for patients requiring NCCT head and radiology reporting workflow.
* To assess the safety of qER at identifying patients with critical findings on NCCT heads.
* To evaluate the technical performance of qER.
* To conduct a Heath Economic, cost utility analysis of qER.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-implementation of qER
Baseline data:
During the pre-implementation phase, we will be gathering data around the technical requirements for integrating qER into the radiology workflow. A random sample of 500 scans per site will be sent for the ground-truthing process for the purpose of technical evaluation.
We will also be collecting data on the baseline status of all the endpoints including TAT. The reporting of NCCT scans will follow the same workflow as the current standard of care (i.e., the images/cases will appear in the RIS chronologically and the radiologist either follows this order or prioritises some cases based on communication from ED).
No interventions assigned to this group
Post-implementation of qER
Post-implementation (Trial Intervention)
In the post-implementation phase, there will be a notification (prioritised flag) in RIS. The order of the cases in RIS will not be altered. When the radiologist clicks a case in RIS, a secondary capture of qER along with the original images will be available in PACS. This secondary capture will have a contour showing the algorithm's attention point for a specific abnormality. The radiologist can then choose to agree with qER findings as it is or modify or ignore it according to their clinical judgement, writing and finally signing off the report. For scans which were not processed by qER the radiologist can prioritise and report as per the standard of care.
qER (qER EU 2.0)
Qure.ai's emergency room software solution qER (qER EU 2.0) is an AI medical device, developed by training a deep-learning algorithm using over 300,000 scans labelled by expert radiologists. qER has been shown to be accurate in identifying a range of abnormalities in NCCT head scans as well as prioritising them for urgent review and radiologist reporting. It is designated as a clinical support tool and, when used with original scans, can assist the clinician to improve efficiency, accuracy, and turnaround time in reading head CTs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
qER (qER EU 2.0)
Qure.ai's emergency room software solution qER (qER EU 2.0) is an AI medical device, developed by training a deep-learning algorithm using over 300,000 scans labelled by expert radiologists. qER has been shown to be accurate in identifying a range of abnormalities in NCCT head scans as well as prioritising them for urgent review and radiologist reporting. It is designated as a clinical support tool and, when used with original scans, can assist the clinician to improve efficiency, accuracy, and turnaround time in reading head CTs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-contrast axial CT scan series with consistently spaced axial slices.
* Soft reconstruction kernel covering the complete Brain.
* Maximum slice thickness of 6mm.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qure.ai
UNKNOWN
NHS Greater Glasgow and Clyde
OTHER
Northumbria Healthcare NHS Foundation Trust
OTHER
Oxford University Hospitals NHS Trust
OTHER
Guy's and St Thomas' NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haris Shuaib, MSc
Role: STUDY_CHAIR
Guy's and St.Thomas' Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHS Greater Glasgow and Clyde
Glasgow, , United Kingdom
Guy's and St.Thomas Trusts
London, , United Kingdom
Northumbria Healthcare NHS Foundation Trust
Northumberland, , United Kingdom
Oxford University Hospitals
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Vimalesvaran K, Robert D, Kumar S, Kumar A, Narbone M, Dharmadhikari R, Harrison M, Ather S, Novak A, Grzeda M, Gooch J, Woznitza N, Hall M, Shuaib H, Lowe DJ. Assessing the effectiveness of artificial intelligence (AI) in prioritising CT head interpretation: study protocol for a stepped-wedge cluster randomised trial (ACCEPT-AI). BMJ Open. 2024 Jun 16;14(6):e078227. doi: 10.1136/bmjopen-2023-078227.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
313507
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.